Table 3.
Variable | GAP points | No. of patients |
---|---|---|
Gender | ||
Female | 0 | 27 (13.0) |
Male | 1 | 180 (87.0) |
Age, years | ||
≤60 | 0 | 71 (34.3) |
61–65 | 1 | 33 (15.9) |
>65 | 2 | 103 (49.8) |
Physiology | ||
FVC, %predicted | ||
>75 | 0 | 105 (50.7) |
50–75 | 1 | 80 (38.6) |
<50 | 2 | 22 (10.6) |
DLco, %predicted | ||
>55 | 0 | 86 (41.5) |
36–55 | 1 | 55 (26.6) |
<35 | 2 | 65 (31.4) |
GAP stage | ||
Stage I | 0–3 | 107 (47.5) |
Stage II | 4–5 | 96 (42.6) |
Stage III | 6–8 | 22 (9.9) |